Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-21-004462
Filing Date
2021-06-22
Accepted
2021-06-22 07:00:42
Documents
100
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f10k_062221p.htm 10-K 1095709
2 EXHIBIT 10.2 exh_102.htm EX-10.2 158038
3 EXHIBIT 10.3 exh_103.htm EX-10.3 111864
4 EXHIBIT 10.6 exh_106.htm EX-10.6 82055
5 EXHIBIT 23.1 exh_231.htm EX-23.1 4889
6 EXHIBIT 31.1 exh_311.htm EX-31.1 7915
7 EXHIBIT 31.2 exh_312.htm EX-31.2 7884
8 EXHIBIT 32.1 exh_321.htm EX-32.1 4829
9 EXHIBIT 32.2 exh_322.htm EX-32.2 4881
16 GRAPHIC kpmg.jpg GRAPHIC 7587
17 GRAPHIC kpmglogo.jpg GRAPHIC 2334
18 GRAPHIC kpmg_logo.jpg GRAPHIC 3498
19 GRAPHIC kpmg_footer.jpg GRAPHIC 16259
20 GRAPHIC kpmg_logo2.jpg GRAPHIC 6689
21 GRAPHIC kpmg_logo3.jpg GRAPHIC 5044
  Complete submission text file 0001171843-21-004462.txt   6542513

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE acst-20210331.xml EX-101.INS 1103708
11 XBRL SCHEMA FILE acst-20210331.xsd EX-101.SCH 85517
12 XBRL CALCULATION FILE acst-20210331_cal.xml EX-101.CAL 50164
13 XBRL DEFINITION FILE acst-20210331_def.xml EX-101.DEF 479897
14 XBRL LABEL FILE acst-20210331_lab.xml EX-101.LAB 423384
15 XBRL PRESENTATION FILE acst-20210331_pre.xml EX-101.PRE 524867
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-35776 | Film No.: 211033021
SIC: 2834 Pharmaceutical Preparations